Teladoc Health (NYSE:TDOC) Posts Earnings Results, Misses Expectations By $0.01 EPS

Teladoc Health (NYSE:TDOC) posted its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.01), FiscalAI reports. Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The firm had revenue of $613.85 million for the quarter, compared to analyst estimates of $611.04 million. During the same period in the previous year, the company posted ($0.53) EPS. Teladoc Health’s revenue was down 2.5% on a year-over-year basis. Teladoc Health updated its FY 2026 guidance to -1.050–0.750 EPS and its Q2 2026 guidance to -0.300–0.200 EPS.

Here are the key takeaways from Teladoc Health’s conference call:

• Consolidated results beat guidance — Q1 revenue $614M and adjusted EBITDA $58M, with $751M in cash and net debt/adjusted EBITDA below 0.9x, signaling near-term financial strength.
• Integrated Care showed steady growth and margin expansion — revenue $395M (+1.5% YoY) and adjusted EBITDA $56M (14.2% margin); management expects the shift from subscriptions to visit-based care and new AI-enabled, enhanced 24/7 offerings to become a net tailwind in H2.
• BetterHelp insurance rollout is ahead of plan — live in 30 states + DC, >6,000 credentialed providers, >150M insured lives, and insurance sessions >14,000/week; company now expects to exit 2026 with a BetterHelp insurance run-rate of at least $125M.
• BetterHelp’s direct-to-consumer business remains pressured — Q1 revenue declined 9% YoY to $218M, average paying users fell 9%, and adjusted EBITDA was only $2M (0.9% margin) as cash-pay weakness and insurance-scaling investments weighed on profitability.
• Management reiterated full-year 2026 guidance (revenue $2.48B–$2.58B; adj EBITDA $267M–$306M; FCF $130M–$170M), plans a two-phase approach to reduce 2027 convertible-related gross debt, and expects stock-based comp to fall below $55M, indicating disciplined capital and cost management.

Teladoc Health Stock Performance

NYSE:TDOC traded up $0.07 during mid-day trading on Thursday, hitting $6.55. 2,353,742 shares of the company’s stock traded hands, compared to its average volume of 5,827,610. The firm has a 50 day moving average of $5.81 and a two-hundred day moving average of $6.26. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $9.77. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $1.18 billion, a price-to-earnings ratio of -6.75 and a beta of 2.08.

Insider Buying and Selling at Teladoc Health

In related news, CEO Charles Divita III sold 27,731 shares of the stock in a transaction dated Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total transaction of $152,243.19. Following the completion of the sale, the chief executive officer owned 364,784 shares in the company, valued at $2,002,664.16. This trade represents a 7.06% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of TDOC. Creative Planning raised its position in Teladoc Health by 7.7% in the 3rd quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock valued at $159,000 after buying an additional 1,462 shares during the last quarter. Syon Capital LLC grew its stake in shares of Teladoc Health by 19.1% in the fourth quarter. Syon Capital LLC now owns 14,140 shares of the health services provider’s stock valued at $99,000 after acquiring an additional 2,264 shares in the last quarter. PNC Financial Services Group Inc. grew its position in Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after buying an additional 2,810 shares in the last quarter. HighTower Advisors LLC raised its position in shares of Teladoc Health by 19.2% in the 4th quarter. HighTower Advisors LLC now owns 18,647 shares of the health services provider’s stock valued at $131,000 after buying an additional 2,997 shares in the last quarter. Finally, California State Teachers Retirement System raised its holdings in shares of Teladoc Health by 2.0% during the 2nd quarter. California State Teachers Retirement System now owns 158,537 shares of the health services provider’s stock worth $1,381,000 after buying an additional 3,114 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. JPMorgan Chase & Co. dropped their price target on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating on the stock in a research note on Friday, March 13th. Leerink Partners reduced their price target on Teladoc Health from $8.50 to $5.50 and set a “market perform” rating on the stock in a research note on Thursday, February 26th. Oppenheimer cut their price objective on Teladoc Health from $12.00 to $7.00 and set an “outperform” rating on the stock in a report on Tuesday, March 3rd. Stifel Nicolaus lowered their price objective on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Thursday, February 26th. Finally, Wells Fargo & Company reduced their price objective on shares of Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 26th. Five research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and an average target price of $7.53.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.